The PDXs represented a diverse genetic background: T-ALL 1 carries an activating IL7R mutation that confers a particular aggressive phenotype (54), and BCP-ALL 1 expresses the TCF3-PBX1 fusion protein as a result of the t(1;19) chromosomal translocation. This evidence concerns the gene IL7R and acute lymphoblastic leukemia.